The DZNE and Eisai Co., Ltd. announce that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders.

Evidence of Disturbed Gene Activity in the Brain as a Result of Heart Problems.

New insights into the rare brain disease “Niemann-Pick type C”.

According to current studies, the COVID-19 disease which is caused by the SARS-CoV-2 coronavirus comprises at least five different variants. Researchers from the DZNE and the University of Bonn report on this in the scientific journal “Genome Medicine”. …

A new app will now allow people with ataxia to assess the severity of their disease at home. It is based on the well-known SARA score, which DZNE researchers have now been able to bring into use outside of clinics.

The DZNE is a founding member of CURE-ND, a cluster of European research institutions that aim to jointly address the challenge of neurodegenerative diseases.

Michela Deleidi, a Parkinson’s researcher at the DZNE’s Tübingen site, has been awarded a “Consolidator Grant” of the European Research Council worth about two million euros.

DZNE scientist report in the journal “Cell Stem Cell” that reactive oxygen molecules, also known as “free radicals”, are important for the brain’s ability to adapt – at least in mice.

Studies on the “gut-brain axis”: Bonn and Tübingen receive 1.5 million US dollars each in funding

In “Nature Neuroscience”, researchers from the DZNE and the Hertie Institute for Clinical Brain Research present new findings on the early development of Alzheimer's disease.